FTY720 Treatment in the Convalescence Period Improves Functional Recovery and Reduces Reactive Astrogliosis in Photothrombotic Stroke

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Brunkhorst, Robert ^a   Kanaan, Nathalie ^a   Koch, Alexander ^a   Ferreirós, Nerea ^a   Mirceska, Ana ^a   Zeiner, Pia ^a   Mittelbronn, Michel ^a   Derouiche, Amin ^a   Steinmetz, Helmuth ^a   Foerch, Christian ^a   Pfeilschifter, Josef ^a   Pfeilschifter, Waltraud ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FINGOLIMOD; GLIAL FIBRILLARY ACIDIC PROTEIN; POSTSYNAPTIC DENSITY PROTEIN 95; SPHINGOSINE 1 PHOSPHATE; VASCULOTROPIN A;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BRAIN CORTEX; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CONVALESCENCE; IMMUNOFLUORESCENCE; MALE; MOUSE; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; POSTSYNAPTIC DENSITY; PROTEIN EXPRESSION; TANDEM MASS SPECTROMETRY; TREATMENT OUTCOME;

ALDEHYDE-LYASES; ANIMALS; ASTROCYTES; CEREBRAL CORTEX; CONVALESCENCE; GENE EXPRESSION; GLIOSIS; IMMUNOSUPPRESSIVE AGENTS; INTRACRANIAL THROMBOSIS; MALE; MICE; MICE, INBRED C57BL; POST-SYNAPTIC DENSITY; PROPYLENE GLYCOLS; RECOVERY OF FUNCTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPHINGOSINE; STROKE; TIME FACTORS; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84881130975     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070124     Document Type: Article

References (44)

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, et al. (2012) Heart Disease and Stroke Statistics-2013 Update A Report From the American Heart Association. Circulation 127: 143-152.
2. Kelly-Hayes M, Beiser A, Kase CS, Scaramucci A, D'Agostino RB, et al. (2003) The influence of gender and age on disability following ischemic stroke: the Framingham study. Journal of Stroke and Cerebrovascular Diseases 12: 119-126.
3. Lo EH, (2008) A new penumbra: transitioning from injury into repair after stroke. Nature Medicine 14: 497-500.
4. Czech B, Pfeilschifter W, Mazaheri-Omrani N, Strobel MA, Kahles T, et al. (2009) The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia. Biochemical and Biophysical Research Communications 389: 251-256.
5. Wei Y, Yemisci M, Kim HH, Yung LM, Shin HK, et al. (2010) Fingolimod provides long-term protection in rodent models of cerebral ischemia. Annals of Neurology 69: 119-129.
6. Hasegawa Y, Suzuki H, Sozen T, Rolland W, Zhang JH, (2010) Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats. Stroke 41: 368-374.
7. Sofroniew MV, (2009) Molecular dissection of reactive astrogliosis and glial scar formation. Trends in Neurosciences 32: 638-647.
8. Zamanian JL, Xu L, Foo LC, Nouri N, Zhou L, et al. (2012) Genomic analysis of reactive astrogliosis. The Journal of Neuroscience 32: 6391-6410.
9. Overman JJ, Clarkson AN, Wanner IB, Overman WT, Eckstein I, et al. (2012) A role for ephrin-A5 in axonal sprouting, recovery, and activity-dependent plasticity after stroke. Proceedings of the National Academy of Sciences of the United States of America 109: E2230-2239.
10. Zhao BQ, Wang S, Kim HY, Storrie H, Rosen BR, et al. (2006) Role of matrix metalloproteinases in delayed cortical responses after stroke. Nature Medicine 12: 441-445.
11. Pebay A, Toutant M, Premont J, Calvo CF, Venance L, et al. (2001) Sphingosine-1-phosphate induces proliferation of astrocytes: regulation by intracellular signalling cascades. The European Journal of Neuroscience 13: 2067-2076.
12. Sorensen SD, Nicole O, Peavy RD, Montoya LM, Lee CJ, et al. (2003) Common signaling pathways link activation of murine PAR-1, LPA, and S1P receptors to proliferation of astrocytes. Molecular Pharmacology 64: 1199-1209.
13. Choi JW, Gardell SE, Herr DR, Rivera R, Lee CW, et al. (2010) FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation. Proceedings of the National Academy of Sciences of the United States of America.
14. Norimatsu Y, Ohmori T, Kimura A, Madoiwa S, Mimuro J, et al. (2012) FTY720 improves functional recovery after spinal cord injury by primarily nonimmunomodulatory mechanisms. The American Journal of Pathology 180: 1625-1635.
15. Clarkson AN, Overman JJ, Zhong S, Mueller R, Lynch G, et al. (2011) AMPA receptor-induced local brain-derived neurotrophic factor signaling mediates motor recovery after stroke. The Journal of neuroscience: the official journal of the Society for Neuroscience 31: 3766-3775.
16. Dumitriu D, Berger SI, Hamo C, Hara Y, Bailey M, et al. (2012) Vamping: Stereology-based automated quantification of fluorescent puncta size and density. Journal of Neuroscience Methods 209: 97-105.
17. Schmidt H, Schmidt R, Geisslinger G, (2006) LC-MS/MS-analysis of sphingosine-1-phosphate and related compounds in plasma samples. Prostaglandins & other lipid mediators 81: 162-170.
18. Brown CE, Wong C, Murphy TH, (2008) Rapid morphologic plasticity of peri-infarct dendritic spines after focal ischemic stroke. Stroke 39: 1286-1291.
19. Schaar KL, Brenneman MM, Savitz SI, (2010) Functional assessments in the rodent stroke model. Experimental & Translational Stroke Medicine 2: 13.
20. Karetko-Sysa M, Skangiel-Kramska J, Nowicka D, (2011) Disturbance of perineuronal nets in the perilesional area after photothrombosis is not associated with neuronal death. Experimental Neurology 231: 113-126.
21. Van Hoecke M, Prigent-Tessier A, Bertrand N, Prevotat L, Marie C, et al. (2005) Apoptotic cell death progression after photothrombotic focal cerebral ischaemia: effects of the lipophilic iron chelator 2,2′-dipyridyl. The European Journal of Neuroscience 22: 1045-1056.
22. Kharlamov A, Guidotti A, Costa E, Hayes R, Armstrong D, (1993) Semisynthetic sphingolipids prevent protein kinase C translocation and neuronal damage in the perifocal area following a photochemically induced thrombotic brain cortical lesion. The Journal of Neuroscience 13: 2483-2494.
23. Chang YY, Fujimura M, Morita-Fujimura Y, Kim GW, Huang CY, et al. (1999) Neuroprotective effects of an antioxidant in cortical cerebral ischemia: prevention of early reduction of the apurinic/apyrimidinic endonuclease DNA repair enzyme. Neuroscience Letters 277: 61-64.
24. Snape MF, Baldwin HA, Cross AJ, Green AR, (1993) The effects of chlormethiazole and nimodipine on cortical infarct area after focal cerebral ischaemia in the rat. Neuroscience 53: 837-844.
25. Porritt MJ, Andersson HC, Hou L, Nilsson A, Pekna M, et al. (2012) Photothrombosis-induced infarction of the mouse cerebral cortex is not affected by the Nrf2-activator sulforaphane. PloS one 7: e41090.
26. Kim ES, Kim JS, Kim SG, Hwang S, Lee CH, et al. (2011) Sphingosine 1-phosphate regulates matrix metalloproteinase-9 expression and breast cell invasion through S1P3-Galphaq coupling. Journal of Cell Science 124: 2220-2230.
27. Kim BG, Dai HN, McAtee M, Vicini S, Bregman BS, (2006) Remodeling of synaptic structures in the motor cortex following spinal cord injury. Experimental Neurology 198: 401-415.
28. Wallace W, Bear MF, (2004) A morphological correlate of synaptic scaling in visual cortex. The Journal of Neuroscience 24: 6928-6938.
29. Noguchi J, Matsuzaki M, Ellis-Davies GC, Kasai H, (2005) Spine-neck geometry determines NMDA receptor-dependent Ca2+ signaling in dendrites. Neuron 46: 609-622.
30. Harris KM, Stevens JK, (1989) Dendritic spines of CA 1 pyramidal cells in the rat hippocampus: serial electron microscopy with reference to their biophysical characteristics. The Journal of neuroscience: the official journal of the Society for Neuroscience 9: 2982-2997.
31. Licht T, Goshen I, Avital A, Kreisel T, Zubedat S, et al. (2011) Reversible modulations of neuronal plasticity by VEGF. Proceedings of the National Academy of Sciences of the United States of America 108: 5081-5086.
32. Hermann DM, Zechariah A, (2009) Implications of vascular endothelial growth factor for postischemic neurovascular remodeling. Journal of Cerebral Blood Flow and Metabolism 29: 1620-1643.
33. Barouk S, Hintz T, Li P, Duffy AM, MacLusky NJ, et al. (2011) 17beta-estradiol increases astrocytic vascular endothelial growth factor (VEGF) in adult female rat hippocampus. Endocrinology 152: 1745-1751.
34. Alvarez-Sabin J, Delgado P, Abilleira S, Molina CA, Arenillas J, et al. (2004) Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: relationship to clinical and radiological outcome. Stroke 35: 1316-1322.
35. Zhang ZG, Zhang L, Jiang Q, Zhang R, Davies K, et al. (2000) VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. The Journal of Clinical Investigation 106: 829-838.
36. Masuko K, Murata M, Beppu M, Nakamura H, Kato T, et al. (2012) Sphingosine-1-phosphate modulates expression of vascular endothelial growth factor in human articular chondrocytes: a possible new role in arthritis. International Journal of Rheumatic Diseases 15: 366-373.
37. Sun HY, Wei SP, Xu RC, Xu PX, Zhang WC, (2010) Sphingosine-1-phosphate induces human endothelial VEGF and MMP-2 production via transcription factor ZNF580: novel insights into angiogenesis. Biochemical and Biophysical Research Communications 395: 361-366.
38. Schmid G, Guba M, Ischenko I, Papyan A, Joka M, et al. (2007) The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1. Journal of Cellular Biochemistry 101: 259-270.
39. Deogracias R, Yazdani M, Dekkers MP, Guy J, Ionescu MC, et al. (2012) Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome. Proceedings of the National Academy of Sciences of the United States of America 109: 14230-14235.
40. Kimura A, Ohmori T, Kashiwakura Y, Ohkawa R, Madoiwa S, et al. (2008) Antagonism of sphingosine 1-phosphate receptor-2 enhances migration of neural progenitor cells toward an area of brain. Stroke 39: 3411-3417.
41. Yatomi Y, Igarashi Y, Yang L, Hisano N, Qi R, et al. (1997) Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. Journal of Biochemistry 121: 969-973.
42. Brinkmann V, Davis MD, Heise CE, Albert R, Cottens S, et al. (2002) The immune modulator FTY720 targets sphingosine 1-phosphate receptors. The Journal of Biological Chemistry 277: 21453-21457.
43. Fischer I, Alliod C, Martinier N, Newcombe J, Brana C, et al. (2011) Sphingosine kinase 1 and sphingosine 1-phosphate receptor 3 are functionally upregulated on astrocytes under pro-inflammatory conditions. PloS one 6: e23905.
44. Carmichael ST, (2005) Rodent models of focal stroke: size, mechanism, and purpose. NeuroRx 2: 396-409.